Abstract:Skeletal muscle wasting, whether related to physiological ageing, muscle disuse or to an underlying chronic disease, is a key determinant to quality of life and mortality. However, cellular basis responsible for increased catabolism in myocytes often remains unclear. Although myocytes represent the vast majority of skeletal muscle cellular population, they are surrounded by numerous cells with various functions. Animal models, mostly rodents, can help to decipher the mechanisms behind this highly dynamic process, by allowing access to every muscle as well as time‐course studies. Satellite cells (SCs) play a crucial role in muscle regeneration, within a niche also composed of fibroblasts and vascular and immune cells. Their proliferation and differentiation is altered in several models of muscle wasting such as cancer, chronic kidney disease or chronic obstructive pulmonary disease (COPD). Fibro‐adipogenic progenitor cells are also responsible for functional muscle growth and repair and are associated in disease to muscle fibrosis such as in chronic kidney disease. Other cells have recently proven to have direct myogenic potential, such as pericytes. Outside their role in angiogenesis, endothelial cells and pericytes also participate to healthy muscle homoeostasis by promoting SC pool maintenance (so‐called myogenesis–angiogenesis coupling). Their role in chronic diseases muscle wasting has been less studied. Immune cells are pivotal for muscle repair after injury: Macrophages undergo a transition from the M1 to the M2 state along with the transition between the inflammatory and resolutive phase of muscle repair. T regulatory lymphocytes promote and regulate this transition and are also able to activate SC proliferation and differentiation. Neural cells such as terminal Schwann cells, motor neurons and kranocytes are notably implicated in age‐related sarcopenia. Last, newly identified cells in skeletal muscle, such as telocytes or interstitial tenocytes could play a role in tissular homoeostasis. We also put a special focus on cellular alterations occurring in COPD, a chronic and highly prevalent respiratory disease mainly linked to tobacco smoke exposure, where muscle wasting is strongly associated with increased mortality, and discuss the pros and cons of animal models versus human studies in this context. Finally, we discuss resident cells metabolism and present future promising leads for research, including the use of muscle organoids.

Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown

Understanding the role of smoking and chronic excess alcohol consumption on reduced caloric intake and the development of sarcopenia

Effects of Cigarette Smoking Associated with Sarcopenia in Persons 60 Years and Older: a Cross-Sectional Study in Zhejiang Province

Associations between sarcopenia and depression in middle-aged and older adults: the moderating effect of smoking

Integrated Multi-Omics Analysis Identifies Disrupted Branched-Chain Amino Acid Catabolism As Causal for Sarcopenia

Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease

A Combination of Serum Biomarkers in Elderly Patients with Sarcopenia: A Cross-Sectional Observational Study

Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis

Sarcopenia: Molecular regulatory network for loss of muscle mass and function

Molecular and Cellular Aspects of Sarcopenia, Muscle Healthy Aging and Physical Conditioning in the Elderly

Pathogenesis of sarcopenia in chronic obstructive pulmonary disease

Experimental models as a tool for research on sarcopenia: A narrative review

Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models

Pathophysiology of sarcopenia: Genetic factors and their interplay with environmental factors

Dysregulated Myokines and Signaling Pathways in Skeletal Muscle Dysfunction in a Cigarette Smoke–induced Model of Chronic Obstructive Pulmonary Disease

Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction

Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia

Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials

Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia

Recent advances in cell-based and cell-free therapeutic approaches for sarcopenia

The Recent Research Progress on Relationship Between Sarcopenia and Chronic Obstructive Pulmonary Disease